Table 2.
Differences in the proportions of patients that reported positive outcomes to gut-directed hypnotherapy (GDH) by demographics and pretreatment preferences
Patient factors | ≥ 30% improvement overall symptoms | ≥ 30% improvement in abdominal pain | Patient reported would not have had further benefit from face-to-face | Would recommend remote GDH to friend/family member with similar symptoms |
Gender distribution (females vs males) | 22/36 (61%) vs 8/16 (50%), p=0.66 | 19/36 (53%) vs 5/16 (31%), p=0.26 | 20/36 (56%) vs 12/16 (75%), p=0.31 | 31/36 (86%) vs 16/16 (100%), p=0.15 |
Age group (>41 vs <41 years) | 17/29 (59%) vs 13/23 (57%), p>0.99 | 12/29 (41%) vs 12/23 (52%), p=0.62 | 19/29 (66%) vs 13/23 (57%), p=0.71 | 27/29 (93%) vs 20/23 (87%) p=0.50 |
Preference for remote GDH at outset vs those that would have opted for face to face | 15/27 (56%) vs 15/25 (60%), p=0.97 | 12/27 (44%) vs 12/25 (48%), p>0.99 | 21/27 (78%) vs 11/25 (44%), p=0.01* | 26/27 (96%) vs 21/25 (84%), p=0.18 |
Distance from treatment centre >20 miles to residence vs those that live <20 miles away | 11/19 (58%) vs 19/33 (58%), p=0.98 | 8/19 (42%) vs 16/33 (48%), p=0.66 | 10/19 (53%) vs 22/33 (67%), p=0.32 | 18/19 (95%) vs 29/33 (88%), p=0.64 |